2.6900
+0.3100
+(13.03%)
At close: April 9 at 4:00:02 PM EDT
2.6500
-0.04
(-1.49%)
After hours: April 9 at 4:52:17 PM EDT
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Total Revenue
--
--
210
--
512
Cost of Revenue
--
--
161
--
385
Gross Profit
--
--
49
--
127
Operating Expense
13,608
13,831
11,060
13,875
13,263
Operating Income
-13,608
-13,831
-11,011
-13,875
-13,136
Net Non Operating Interest Income Expense
987
1,133
1,081
104
2
Other Income Expense
--
--
--
--
6
Pretax Income
-12,621
-12,698
-9,930
-13,771
-13,128
Net Income Common Stockholders
-12,483
-12,554
-9,811
-13,595
-12,954
Diluted NI Available to Com Stockholders
-12,483
-12,554
-9,811
-13,595
-12,954
Basic EPS
-0.39
-0.39
-0.32
-0.45
-0.45
Diluted EPS
-0.39
-0.39
-0.32
-0.45
-0.45
Basic Average Shares
32,085.7500
31,898
30,980
30,374
28,579
Diluted Average Shares
32,085.7500
31,898
30,980
30,374
28,579
Total Operating Income as Reported
-13,608
-13,831
-11,011
-13,875
-13,136
Total Expenses
13,608
13,831
11,221
13,875
13,648
Net Income from Continuing & Discontinued Operation
-12,483
-12,554
-9,811
-13,595
-12,954
Normalized Income
-12,483
-12,554
-9,811
-13,595
-12,960
Interest Income
987
1,133
1,081
104
2
Net Interest Income
987
1,133
1,081
104
2
EBIT
-13,608
-13,831
-11,011
-13,875
-13,136
EBITDA
-13,575
-13,794
-10,965
-13,833
-13,076
Reconciled Cost of Revenue
--
--
161
--
385
Reconciled Depreciation
33
37
46
42
60
Net Income from Continuing Operation Net Minority Interest
-12,483
-12,554
-9,811
-13,595
-12,954
Total Unusual Items Excluding Goodwill
--
--
--
--
6
Total Unusual Items
--
--
--
--
6
Normalized EBITDA
-13,575
-13,794
-10,965
-13,833
-13,082
10/31/2021 - 10/7/1983
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INMB INmune Bio, Inc.
7.63
+11.55%
MNOV MediciNova, Inc.
1.3145
+6.01%
DRMA Dermata Therapeutics, Inc.
0.8065
-0.43%
GLTO Galecto, Inc.
2.4400
+8.93%
SRZN Surrozen, Inc.
9.45
+0.32%
OVID Ovid Therapeutics Inc.
0.2788
+9.33%
SABS SAB Biotherapeutics, Inc.
1.2700
+9.48%
YMAB Y-mAbs Therapeutics, Inc.
4.4500
+8.80%
ARTL Artelo Biosciences, Inc.
0.9199
+6.97%
OSTX OS Therapies Incorporated
1.3400
+2.29%